Alburx Solution
Product Images NDC 44206-251

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Alburx (NDC 44206-251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Ag, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Principal Display Panel (50 mL Vial Label)
Albumin (Human) 25% Solution, brand name AlbuRx® 25, is a medicine for intravenous administration, manufactured by CSLBehring AG in Switzerland and distributed by CSLBehring LLC in the USA. The product contains 125g Albumin (Human) in 50 mL of buffered diluent and is stabilized with 0.02 M sodium caprylate and 0.02 M sodium N-acetyltryptophanate. The medicine is osmotically equivalent to 250 mL of plasma, with a Sodium content of 0.14 M. It is packed in a single-dose vial of 50 mL with complete directions for use. Patients and physicians should discuss the risks and benefits of this product. The package insert contains directions for use and product dosage information. It is essential to note that the medicine must not be used if it is turbid, and administration must not begin more than 4 hours after the container has been entered. Additionally, partially used vials should be discarded, and in cases of marked dehydration, additional fluids must accompany or follow the administration of albumin. The medicine contains no preservative and should be stored at room temperature not exceeding 30°C (86°F).*
FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Principal Display Panel (50 mL Vial Carton)
This is a description of a medical product, specifically a 25% solution of Albumin (Human) called AlbuRx® 25, for intravenous administration. It comes in a 100 mL single-dose vial, and the package contains complete instructions for use. It is stabilized with 0.02 M sodium N-acetyltryptophanate and 0.02 M sodium caprylate and is osmotically equivalent to 500 mL of plasma. It contains no preservative and should not be used if turbid. Dehydration should be treated with additional fluids either before or after administering AlbuRx® 25. Patients and physicians should discuss the risks and benefits of using this product. It is manufactured by CSLBehring AG and distributed by CSL Behring LLC based in Kankakee, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.